Actively Recruiting
Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block
Led by Tongji Hospital · Updated on 2024-05-31
252
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. Efficacy of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy 2. Safety of a modified auriculotemporal nerve blockade for patients undergoing supratentorial craniotomy
CONDITIONS
Official Title
Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing supratentorial craniotomy under general anesthesia
- Age between 18 and 65 years
- American Society of Anesthesiologists (ASA) physical status I or II
You will not qualify if you...
- Emergency surgery
- Allergy to ropivacaine
- Participation in another clinical trial within 30 days
- Skin infection at the injection site
- Use of analgesic drugs before surgery
- Alcohol or drug addiction
- Severe liver or kidney dysfunction
- Coagulation disorders
- Pregnant or breastfeeding women
- Consciousness disorder before surgery
- Neurosurgery within the last 6 months
- Inability to understand the numerical rating scale (NRS) before surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji Hospital
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
F
Feng Gao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here